About this item:

512 Views | 0 Downloads

Author Notes:

Correspondence to: Kimford J. Meador, MD, Department of Neurology, Emory University, Woodruff Memorial Research Building, 101 Woodruff Circle, Suite 6000, Atlanta, GA 30322, USA E-mail: kimford.meador@emory.edu

The members of the NEAD Study Group are provided in the Appendix I.

Subject:

Research Funding:

National Institutes of Health (2RO1-NS038455 to K.J.M., R01NS050659 to N.B.); UK Epilepsy Research Foundation (RB219738 to G.A.B.).

Keywords:

  • antiepileptic drugs
  • child development
  • cognitive neurology
  • epilepsy
  • pregnancy

Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age

Show all authors Show less authors

Tools:

Journal Title:

Brain

Volume:

Volume 134, Number 2

Publisher:

, Pages 396-404

Type of Work:

Article | Post-print: After Peer Review

Abstract:

We previously reported that foetal valproate exposure impairs intelligence quotient. In this follow-up investigation, we examined dose-related effects of foetal antiepileptic drug exposure on verbal and non-verbal cognitive measures. This investigation is an ongoing prospective observational multi-centre study in the USA and UK, which has enrolled pregnant females with epilepsy on monotherapy from 1999 to 2004. The study seeks to determine if differential long-term neurodevelopmental effects exist across four commonly used drugs (carbamazepine, lamotrigine, phenytoin and valproate). This report compares verbal versus non-verbal cognitive outcomes in 216 children who completed testing at the age of three years. Verbal and non-verbal index scores were calculated from the Differential Ability Scales, Preschool Language Scale, Peabody Picture Vocabulary Test and Developmental Test of Visual-Motor Integration. Verbal abilities were lower than non-verbal in children exposed in utero to each drug. Preconceptional folate use was associated with higher verbal outcomes. Valproate was associated with poorer cognitive outcomes. Performance was negatively associated with valproate dose for both verbal and non-verbal domains and negatively associated with carbamazepine dose for verbal performance. No dose effects were seen for lamotrigine and phenytoin. Since foetal antiepileptic drug exposure is associated with lower verbal than non-verbal abilities, language may be particularly susceptible to foetal exposure. We hypothesize that foetal drug exposure may alter normal cerebral lateralization. Further, a dose-dependent relationship is present for both lower verbal and non-verbal abilities with valproate and for lower verbal abilities with carbamazepine. Preconceptional folate may improve cognitive outcomes. Additional research is needed to confirm these findings, extend the study to other drugs, define the risks associated with drug treatment for seizures in the neonates, and understand the underlying mechanisms.

Copyright information:

© The Author (2011). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com

Export to EndNote